Search Results - "Appachu, Sandhya"

Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience.

Authors: Sandeep, K. S. Appachu, Sandhya Diwaker, Ravi B. et al.

Source: Indian Journal of Cancer. Oct-Dec2025, Vol. 62 Issue 4, p541-547. 7p.

Clinical Benefit and Safety of Palbociclib in Hormone Positive Breast Cancer with Visceral Metastasis: Real-World Experience from a Tertiary Cancer Center.

Authors: K. S, Sandeep Appachu, Sandhya Diwaker, Ravi B. et al.

Source: Indian Journal of Medical & Paediatric Oncology. Apr2025, Vol. 46 Issue 2, p168-173. 6p.

A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15--a case report.

Authors: Appachu, Sandhya Obulareddy, Chintaparthi Sirsath, Nagesh T. et al.

Source: Ecancermedicalscience. 2013, Vol. 7 Issue 334-360, p1-4. 4p.

The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India.

Authors: Babu, Govind Saldanha, Smitha Carol Kuntegowdanahalli Chinnagiriyappa, Lakshmaiah et al.

Source: Chemotherapy Research & Practice. 1/27/2016, p1-5. 5p. 5 Charts.

Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness.

Authors: Jacob, Linu A. Aparna, S. Lakshmaiah, K. C. et al.

Source: Advances in Hematology. 11/4/2015, p1-6. 6p.